Maxcyte, inc.MXCT.US Overview
MXCT Overall Performance
MXCT AI Analysis & Strategy
MXCT Recent Performance
1.27%
Maxcyte, inc.
0.81%
Avg of Sector
-1.14%
S&P500
MXCT PowerScanner
MXCT Key Information
MXCT Valuation Metrics
MXCT Earnings Table
MXCT Profile
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.